Immunome Inc. – Plans of Reorganization, Merger, Acquisition or Similar – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Plans of Reorganization, Merger, Acquisition or Similar Filter

from 8-K 36 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Asset Purchase Agreement by and Among Zentalis Pharmaceuticals, Inc., Zeno Management, Inc. and Immunome, Inc. Dated as of October 25, 2024

from 8-K 89 pages Asset Purchase Agreement by and Between Ayala Pharmaceuticals, Inc. and Immunome, Inc. Dated as of February 5, 2024

from 425 108 pages Agreement and Plan of Merger and Reorganization by and Among: Immunome, Inc., a Delaware Corporation; Ibiza Merger Sub, Inc., a Delaware Corporation; and Morphimmune Inc., a Delaware Corporation Dated as of June 29, 2023

from 8-K 108 pages Agreement and Plan of Merger and Reorganization by and Among: Immunome, Inc., a Delaware Corporation; Ibiza Merger Sub, Inc., a Delaware Corporation; and Morphimmune Inc., a Delaware Corporation Dated as of June 29, 2023